Verus Capital Partners’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,510
Closed -$222K 420
2024
Q3
$222K Buy
+3,510
New +$222K 0.02% 350
2024
Q2
Sell
-2,700
Closed -$221K 404
2024
Q1
$221K Buy
+2,700
New +$221K 0.02% 318
2020
Q1
$15K Sell
3,100
-200
-6% -$968 ﹤0.01% 895
2019
Q4
$26K Buy
+3,300
New +$26K 0.01% 799